Ultomiris (ravulizumab)
pCPA File Number:
22625
Negotiation Status:
Under consideration for negotiation
Indication(s):
Neuromyelitis optica spectrum disorder (NMOSD)
Sponsor/Manufacturer:
Alexion Pharma Canada Corp.
CADTH Project Number:
SR0785-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable